Literature DB >> 184412

Neoplasia in the rat induced by N-hydroxyphenacetin, a metabolite of phenacetin.

I C Calder, D E Goss, P J Williams, C C Funder, C R Green, K N Ham, J D Tange.   

Abstract

N-hydroxyphenacetin, a phenacetin metabolite, was fed to rats as a 0.05-0.5% dietary supplement. After 9 months, tumours of the liver were found in 36 of 64 animals. One animal also developed a renal tumour. No tumours were found in control animals. The findings implicate phenacetin as a carcinogen and suggest that N-hydroxyphenacetin may be the metabolite responsible.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184412     DOI: 10.3109/00313027609094418

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.

Authors:  M E Veronese; S McLean
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Animal experiments regarding a possible carcinogenic effect of phenacetin on the resting and proliferating urothelium stimulated by cyclophosphamide.

Authors:  E Kunze; H H Wöltjen; B Hartmann; W Engelhardt
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 3.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

4.  N-Hydroxy-N-arylacetamides. I. Toxicity of certain polycyclic and monocyclic N-hydroxy-N-arylacetamides in rats.

Authors:  T Fischbach; H Hertle; M Kiese; W Lenk; H Sterzl; P Meister
Journal:  Arch Toxicol       Date:  1984-12       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.